D.E. Shaw & Co’s ARYA Sciences Acquisition Corp V Class A Ordinary Shares ARYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-55,507
Closed -$574K 4669
2023
Q2
$574K Buy
55,507
+40,506
+270% +$417K ﹤0.01% 3365
2023
Q1
$153K Buy
+15,001
New +$152K ﹤0.01% 3946
2022
Q4
Sell
-136,663
Closed -$1.34M 5290
2022
Q3
$1.34M Buy
136,663
+200
+0.1% +$1.96K ﹤0.01% 3353
2022
Q2
$1.33M Hold
136,463
﹤0.01% 3429
2022
Q1
$1.33M Buy
136,463
+27,500
+25% +$266K ﹤0.01% 3675
2021
Q4
$1.06M Buy
108,963
+80,661
+285% +$791K ﹤0.01% 3887
2021
Q3
$280K Buy
+28,302
New +$281K ﹤0.01% 4400

D.E. Shaw & Co's ARYE Position: Q3 2023 in Review

D.E. Shaw & Co sold out of ARYA Sciences Acquisition Corp V Class A Ordinary Shares (ARYE) in Q3 2023, closing a stake of 55,507 shares — an estimated $574K sold.

D.E. Shaw & Co first reported a position in ARYE in Q3 2021 and held it in 7 quarters. The position peaked at $1.34M in Q3 2022. 0 funds tracked by Wall St. Rank hold ARYE as of Q3 2023.

  • D.E. Shaw & Co reported no remaining ARYA Sciences Acquisition Corp V Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 55,507 ARYA Sciences Acquisition Corp V Class A Ordinary Shares shares in Q3 2023, an estimated $574K.
  • D.E. Shaw & Co first reported a position in ARYA Sciences Acquisition Corp V Class A Ordinary Shares in Q3 2021 and held it in 7 quarters.
  • D.E. Shaw & Co's ARYA Sciences Acquisition Corp V Class A Ordinary Shares position peaked at $1.34M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held ARYA Sciences Acquisition Corp V Class A Ordinary Shares as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.